A detailed history of Ifg Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ifg Advisors, LLC holds 6,118 shares of BMY stock, worth $325,599. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,118
Previous 6,118 -0.0%
Holding current value
$325,599
Previous $254,000 24.41%
% of portfolio
0.07%
Previous 0.06%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $3,550 - $4,025
74 Added 1.22%
6,118 $331,000
Q1 2022

May 18, 2022

BUY
$61.48 - $73.72 $371,585 - $445,563
6,044 New
6,044 $441,000
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $371,585 - $445,563
-6,044 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $5,917 - $6,931
-100 Reduced 1.63%
6,044 $358,000
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $5,819 - $6,337
94 Added 1.55%
6,144 $411,000
Q1 2021

Apr 22, 2021

BUY
$59.34 - $66.74 $359,007 - $403,776
6,050 New
6,050 $382,000
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $348,980 - $395,458
-6,044 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$42.77 - $50.71 $258,501 - $306,491
6,044 New
6,044 $306,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ifg Advisors, LLC Portfolio

Follow Ifg Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisors, LLC with notifications on news.